NCT00184522已完成4 期
Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 82
- 试验地点
- 9
- 主要终点
- Symptomatic relief
研究概览
简要总结
A comparison of the effect of on demand treatment with a pectin-containing natural product (Aflurax) with that esomeprazole (Nexium)
详细描述
A randomized, controlled, open trial comparing the symptomatic effect of a pectin-containing product (Aflurax) with that of esomeprazole (Nexium 20 mg) given on-demand for 6 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Mild and moderate reflux symptoms Age > 17 years Informed consent -
排除标准
- •Other conditions that might explain the symptoms Abuse of drugs or alcohol
研究组 & 干预措施
Aflurax
Experimental
pectin-containing natural product
干预措施: Aflurax (Drug)
esomeprazole (Nexium)
Active Comparator
esomeprazole (Nexium)
干预措施: esomeprazole (Drug)
结局指标
主要结局
Symptomatic relief
次要结局
- Overall satisfaction
研究者
研究点 (9)
Loading locations...
相似试验
已完成
3 期
Ulcer Prevention IINSAID Associated Gastric UlcersNCT00629928AstraZeneca800
已完成
3 期
Chest Pain Pilot StudyChest PainGastroesophageal RefluxNCT00251901AstraZeneca600
已完成
3 期
Prevention of Gastric UlcersNSAID Associated Gastric UlcersNCT00629512AstraZeneca504
已完成
3 期
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is ContinuedNSAID Associated Gastric UlcersNCT00633672AstraZeneca400
已完成
3 期
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US OnlyNSAID Associated Gastric UlcersNCT00633412AstraZeneca400